HC

Hema Channagiri Lakshmeesha

Active Director Director DIN 10398105
DIN 10398105 First appointment Nov 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Hema Channagiri Lakshmeesha

Data last updated:

Hema Channagiri Lakshmeesha is a Director at Kushma Bioscience Private Limited (since 2023). The company operates in Paper.

DIN 10398105
Primary Designation Director
Industry Paper
First Appointment 20 Nov 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Kushma Bioscience Private Limited U21001KA2023PTC181170
Director20 Nov 20232023Active

Board colleagues of Hema Channagiri Lakshmeesha

NameDINCompanyDesignation
Parswanath Sandeep07084263Kushma Bioscience Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kushma Bioscience Private Limited
Premium access

Shareholding and investment profile for Hema Channagiri Lakshmeesha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Channagiri Lakshmeesha

Hema Channagiri Lakshmeesha currently holds 1 directorship: Kushma Bioscience Private Limited (Director, since 20 Nov 2023).

Hema Channagiri Lakshmeesha was first appointed on 20 Nov 2023 as Director at Kushma Bioscience Private Limited.

The current boards of Hema Channagiri Lakshmeesha's companies include Parswanath Sandeep (Kushma Bioscience Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available